For generations, medicine held that higher HDL cholesterol meant a safer heart — a reassuring equation that shaped clinical advice and drove pharmaceutical ambition. A large study drawing on nearly half a million UK Biobank participants now complicates that story, finding that men with very high HDL levels face nearly double the risk of cardiovascular and all-cause death, while women with the same elevated levels show no such penalty. The findings suggest that cholesterol, like most things in biology, resists simple arithmetic — and that the meaning of a number depends deeply on the body in wh
News-Medical.net
· May 23, 2023
· health
· 4 min de leitura
High
Apuração: Verificado
Study challenges 'good cholesterol' myth: very high HDL-C linked to mortality risk in men
◉
Science & Space
6903 artigos relacionados
NASA Launches Artemis II: Four Astronauts Head to Moon in Historic Mis…
Devdiscourse · 100% correspondência
NASA study finds Earth microbes could survive on Moon's South Pole, co…
Texas Public Radio | TPR · 99% correspondência
Blue Origin Probed Over Rocket Failure as Mars Rover Finds Organic Com…
Devdiscourse · 99% correspondência
Israeli radiation vest shows promise for safer deep-space missions
jns.org · 99% correspondência
Starship's Raw Power Masks Mars Challenge: Orbital Refueling Still Unp…
Space Daily · 99% correspondência
Cobertura Relacionada
Al Jazeera · Aug 22
China's Chang'e-7 Aims to Unlock Moon's Water Ice Secrets at South Pole
China's Chang'e-7 unmanned mission launches this week to explore the moon's south pole for water ice in permanently shad…
Bangkok Post · Aug 22 Thailand Opens Cancer Screening Centre at MRT Station to Boost Preventive Care AccessThailand's Transport and Public Health ministries are converting space at an Orange Line MRT station into a cancer preve…
Science Daily · Aug 22 Queen bees transfer pesticides to eggs to protect themselves, study findsHoneybee queens exposed to pesticides shift contamination into their eggs to protect themselves, a survival strategy tha…
Science Daily · Aug 22 Natural tooth count predicts pancreatic cancer survival, study findsPancreatic cancer patients with 21+ natural teeth survived nearly two years longer after surgery than those with fewer t…
Viés e Enquadramento
⚖
Article presents research findings with scientific framing but uses 'myth' language that may oversimplify complex cholesterol science; generally balanced but lacks counterargument perspectives.
Bias Direction
center
Confidence
MED
Challenge-to-conventional-wisdom framing using 'myth' terminology to emphasize novelty of findings; presents research as definitive despite nuanced gender-specific results
challenges 'good cholesterol' myth
very high HDL-C linked to mortality risk
assumption that higher HDL is always protective
Cardiologists or medical professionals defending the traditional HDL-C guidance
Discussion of why this finding contradicts decades of cardiovascular research
Limitations of the study or reasons for gender-specific differences
Clinical implications and whether guidelines should change based on single study
Perspectives from researchers who maintain HDL-C remains protective at these levels
Impacto Geopolítico
🌎
Medical research finding on cholesterol metabolism has no direct geopolitical implications; this is a health science study without international relations significance.
Escalation Risk
low
Confidence
HIGH
Lente Econômica
📈
Research challenges 'good cholesterol' myth: very high HDL levels (>80 mg/100ml) linked to increased cardiovascular mortality in men, potentially disrupting cholesterol management practices and pharmaceutical strategies.
Market Signal
bearish
Confidence
MED
Pharmaceutical/Biotech (statin and HDL-raising drug manufacturers)
Healthcare/Medical Services
Diagnostic Testing/Laboratory Services
Health Insurance
Wellness/Preventive Health Industry
Consumers may experience confusion about cholesterol management goals; potential reduction in demand for HDL-raising medications and supplements; increased healthcare costs from additional testing to determine individual risk profiles; possible changes in preventive health recommendations affecting insurance premiums and out-of-pocket costs.
Regulatory bodies (FDA, EMA) may require updated clinical guidelines for cholesterol management with gender-specific thresholds; potential reassessment of pharmaceutical approvals for HDL-raising drugs; insurance coverage policies may shift; medical education standards may need revision; public health messaging on cholesterol will require clarification.